All the Active Ingredient Drugs
PPI. Esomeprazole 20 mg, Esomeprazole 40 mg. Tab. 20 mg X 7/14/28/50, 40 mg X 7/14/28/50s
Erosive reflux esophagitis; prolonged tmt. after i.v. induced prevent. of rebleeding of peptic ulcer assoc. with NSAIDS ther. .; 40 mg 1 X dly for 4 weeks.
long-term managem. of pts. with healed esophagitis to prev. relapse; symptom. tmt. of gastroesophageal reflux disease (GERD) ; prevent. of gastric and duodenal ulcers associated with NSAID ther. in patients at risk: 20 mg X1 dly. In combin. with an appropr. antibact. ther. for eradic. of Helicobacter pylori: 20 mg X2 dly. Doses for adolesc. are the same as for adults.
Adults for:. GERD- tmt. of erosive reflux esophagitis- long-term managem. of pts. with healed esophagitis to prev. relapse- symptom. tmt. GERD. In comb. with an appropr. antibact. therap. for eradication of Helicobacter pylori and:- healing of Helicobacter pylori assoc. duodenal ulcer and- prevent. of relapse of peptic ulcers in pts. with Helicobacter pylori assoc. ulcers. Pts. req. NSAID ther.- healing of gastr. ulcers assoc. with NSAID ther. – prevent. of gastr. and duodenal ulcers assoc. with NSAID ther. in pts. at risk. Prolong. tmt. after i.v. induced prevent. of rebleed. of peptic ulcers. In adolesc. from the age of 12 years for GERD (only with 20 mg)- tmt. of erosive reflux esophagitis- long-term managem. of pts. with healed esophagitis to prevent relapse- symptom. tmt. of GERD. In combin. with antibiot. in tmt. of duodenal ulcer caused by Helicobacter pylori.
C/I: hypersens. to esomeprazole, substit. benzimidazoles or any other constit. Not to be administr. with nelfinavir
PPI. Esomeprazole 40 mg. Vial. Powd. for infus./inject. 50X 40 mg
Adults:20-40 mg 1 X dly. Transfer to oral ther. asap. GERD with esophagitis: 40 mg 1 X dly. Sympt. tmt. GERD: 20 mg 1 X dly. All as IV, as altern. to oral ther. when oral intake not appropr. Prevent. of rebleed. follow. therap. endoscopy for acute bleed. gastric/duoden. ulcers: 80 mg as a bolus, contin. by 8 mg/h given over 3 days.
Chldr. aged 1-11: 10 mg 1 X dly. Chldr. aged 12-18: 20 mg 1X dly. See prescr. info.
In adlts. for: Gastroesophageal reflux disease (GERD) in pts. with esophagitis and/or sev. sympt. of reflux as an altern. to oral ther. when oral intake is not appropr / Prevent. of rebleed. follow therap. endoscopy for ac. bleeding gastric or duodenal ulcers.
In child. and adolesc. aged 1-18 years for: Gastric antisecret. tmt. when oral route is not possible, such as GERD in pts. with erosive reflux esophagitis and/or sev. sympt. of reflux.
C/I: : hypersens. to esomeprazole, substit. benzimidazoles or any other constit. Not to be administr. with nelfinavir
PPI. Esomeprazole 20 mg. H.Caps 7/14 X 20 mg
1 X dly for a max of 2 wks.
for the short-term tmt. of reflux sympt. (e.g. heartburn and acid regurgit.) in adlts.
C/I: Hypersens., incl. to substit. benzimidazoles.
Not be used concom. with nelfinavir
PPI. Esomeprazole 20 mg, Esomeprazole 40 mg. H.Caps. 28 X 20 mg/40 mg
Adlts.:Gastroesophageal Reflux Disease (GERD)
- tmt. of erosive reflux esophagitis:
40 mg 1 X dly. for 4 weeks
-long-term manag. of ptts. with healed esophagitis to prev. relapse:20 mg 1X dly.
- symptom. tmt. of GERD:
20 mg 1X dly
Eradic. of H. pylori: 20 mg+ 1g amoxicillin+ 500 mg clarithromycin, all 2 Xdly for 7 days.
For ptt. under NSAID ther.: 20 mg X1 dly.
Prolonged tmt. after i.v. induced prevent. of rebleed. of peptic ulcers: 40 mg 1 X dly. for 4 weeks
Adolesc from the age of 12: dosage as for adlts. For comb. antibiot. as per ptt. weight.
Adlts. for:Gastroesophageal Reflux Disease (GERD)- tmt. of erosive reflux esophagitis - long-term manag. of ptts. with healed esophagitis to prev. relapse – symptom. tmt. of GERD. In combin. with appropr. antibact. ther. regimens for the eradic. of Helicobacter pylori and- healing of H. pylori assoc. duodenal ulcer and prevent. of relapse of peptic ulcers in ptts. with H. pylori assoc. ulcers -Ptts. req. continued NSAID ther. Healing of gastric ulcers assoc. with NSAID ther.– Prevent. of gastric and duodenal ulcers assoc. with NSAID ther., in ptts at risk. - Prolonged tmt. after i.v. induced prevent. of rebleed. of peptic ulcers. Adolesc. from the age of 12 for: GERD – tmt. of erosive reflux esophagitis -long-term manag. of ptts. with healed esophagitis to prev. relapse-Symptom. tmt. of GERD. In combin. with antibiotics in tmt. of duodenal ulcer caused by H. pylori.
C/I: hypersens. incl. to substituted benzimidazoles.
Not to be admin. with nelfinavir.
PPI. Esomeprazole (as sodium) 40 mg. VIALS (pwdr. for sol.): 10 x 40 mg. 20-40
mg 1 x dly. GERD: 40 mg 1 x dly. Sympt.
tmt. GERD: 20 mg 1 x dly all by IV tmt
which is usually of short durat. Transfer
to oral tmt as soon as possible. Not to
be used in child, no dose adjust. reqd. in
impair. ren/hepat. function unless
severe. See lit. Elderly: No dose adjust.
reqd.
GERD in pts. with esophagit. and/or
severe sympts. reflux, as alt. to oral ther.
when oral intake not appropriate.
Prevent. rebleed. foll. therapeut.
endoscopy for acute bleed. gastric/
duoden. ulcers.
C/I: Hypersens.
PPI. Esomeprazole 20 mg, 40 mg. TAB: 7, 14, 28 x 20 mg; 7, 28 x 40 mg.
GERD: Tmt. of erosive GERD: 40 mg 1 x
dly for 4 wks. Addit. 4 wks. tmt.
recommend. for pts. with whom
esophagit. has not healed or who have
persistent sympts. Long-term manage.
pts with healed esophagit. to prevent
relapse: 20 mg 1 x dly. Sympt. tmt.
GERD: 20 mg 1 x dly in pts without
esophagit. See lit. In combin with
approp. antibacter. therap. regimens
for the eradicat. of H. pylori and
healing of H. pylori assoc. duod. ulc.
and prevent. relapse of pept. ulc. in pts
with H. pylori assoc. ulcers: 20 mg with
1 g amoxicillin and 500 mg
clarithromycin, all 2 x dly for 7 days.
Not to be used in child.
Prolonged tmt. aft. I.V. induced prevent.
rebleed. pept. ulcers. Pts. req. NSAID ther.
